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The gastrointestinal tract, the largest human microbial reservoir, is highly dynamic. The gut
microbes play essential roles in causing colorectal diseases. In the present study, we
explored potential keystone taxa during the development of colorectal diseases in central
China. Fecal samples of some patients were collected and were allocated to the adenoma
(Group A), colorectal cancer (Group C), and hemorrhoid (Group H) groups. The 16S rRNA
amplicon and shallow metagenomic sequencing (SMS) strategies were used to recover
the gut microbiota. Microbial diversities obtained from 16S rRNA amplicon and SMS data
were similar. Group C had the highest diversity, although no significant difference in
diversity was observed among the groups. The most dominant phyla in the gut microbiota
of patients with colorectal diseases were Bacteroidetes, Firmicutes, and Proteobacteria,
accounting for >95% of microbes in the samples. The most abundant genera in the
samples were Bacteroides, Prevotella, and Escherichia/Shigella, and further species-level
and network analyses identified certain potential keystone taxa in each group. Some of
the dominant species, such as Prevotella copri, Bacteroides dorei, and Bacteroides
vulgatus, could be responsible for causing colorectal diseases. The SMS data
recovered diverse antibiotic resistance genes of tetracycline, macrolide, and beta-
lactam, which could be a result of antibiotic overuse. This study explored the gut
microbiota of patients with three different types of colorectal diseases, and the
microbial diversity results obtained from 16S rRNA amplicon sequencing and SMS
data were found to be similar. However, the findings of this study are based on a
limited sample size, which warrants further large-scale studies. The recovery of gut
microbiota profiles in patients with colorectal diseases could be beneficial for future
diagnosis and treatment with modulation of the gut microbiota. Moreover, SMS data
can provide accurate species- and gene-level information, and it is economical. It can
therefore be widely applied in future clinical metagenomic studies.






Xuzhou Medical University, China
Shuangling Luo,






This article was submitted to
Molecular Diagnostics and
Therapeutics,
a section of the journal
Frontiers in Molecular Biosciences.
Received: 30 April 2021
Accepted: 15 June 2021
Published: 09 July 2021
Citation:
Liu Y, Li X, Yang Y, Liu Y, Wang S, Ji B
and Wei Y (2021) Exploring Gut
Microbiota in Patients with Colorectal
Disease Based on 16S rRNA Gene
Amplicon and Shallow
Metagenomic Sequencing.
Front. Mol. Biosci. 8:703638.
doi: 10.3389/fmolb.2021.703638
Frontiers in Molecular Biosciences | www.frontiersin.org July 2021 | Volume 8 | Article 7036381
ORIGINAL RESEARCH
published: 09 July 2021
doi: 10.3389/fmolb.2021.703638
INTRODUCTION
According to global cancer statistics 2020 by GLOBOCAN,
among the 36 kinds of cancers, colorectal cancer is the third
most common malignancy and the second most lethal tumor in
185 countries (Sung et al., 2021). It is associated with a high
mortality rate, with 0.93 million deaths reported worldwide in
2020 (Sung et al., 2021). Research suggests that genetic factors are
responsible for 12–35% of all colorectal cancers (Lichtenstein
et al., 2000; Czene et al., 2002; Song et al., 2020; Rajamäki et al.,
2021). The human intestine is the largest microbial reservoir. The
number of gut microbes is nearly equal to that of the cells present
in the entire body (Wang et al., 2017), while the number of genes
from the gut microbiota is 100-fold greater than that from the
human genome (Bilen et al., 2018). Intestinal microbes are
associated with diverse colorectal diseases, including colorectal
carcinoma (Wong and Yu, 2019; Schmitt and Greten, 2021; Xing
et al., 2021).
Previous studies have reported the association of some
important gut microbial species with colorectal cancer (Dai
et al., 2018; Wirbel et al., 2019; Yachida et al., 2019).
Fusobacterium nucleatum (Brennan and Garrett, 2019;
Rubinstein et al., 2019), certain Escherichia coli strains
(Wassenaar, 2018), some Bacteroides fragilis strains (Sears
et al., 2014; Chung et al., 2018), and several other bacterial
species have been linked to colorectal cancer (Dai et al., 2018;
Butt et al., 2021). Some of these strains induce colorectal
carcinogenesis by generating metabolites or toxins (Wong and
Yu, 2019). A driver–passenger model was proposed for assessing
the genetic pattern of colorectal cancer progression (Tjalsma
et al., 2012). The driver microbes, including the toxigenic
microbes of E. coli and B. fragilis strains, damaged the host
DNA and disrupted colonic barriers (Cuevas-Ramos et al.,
2010; Goodwin et al., 2011; Pleguezuelos-Manzano et al., 2020;
Butt et al., 2021; Lopez et al., 2021), whereas the passenger
microbes, such as F. nucleatum, proliferated in the suitable
niche created by the driver microbes (Tjalsma et al., 2012;
Shang and Liu, 2018). The dysbiosis of the micro-niche may
lead to colorectal cancer (Brennan and Garrett, 2016; Tilg et al.,
2018). Similarly, microbial profiling of gastric cancer samples
suggested that Helicobacter pylori may be the driver microbe and
several opportunistic pathogenic microbes may directly cause
gastric cancer (Li et al., 2021).
Colorectal adenoma is the main precursor of most colorectal
cancers (Corley et al., 2014; Click et al., 2018). Hemorrhoid is a
common colorectal disease with symptoms different from those
of colorectal adenoma and colorectal cancer (Jandhyala et al.,
2015). Therefore, exploring the gut microbiota of different
colorectal diseases could reveal the microbial mechanism of
action in colorectal carcinogenesis. The 16S rRNA gene
amplicon and metagenomic strategies are commonly used
to study the complex gut microbiota involved in colorectal
diseases, including colorectal cancer (Flemer et al., 2017; Saito
et al., 2019). The 16S rRNA gene amplicon sequencing
provides insight into the diversity of microbial communities
at the genus level, whereas the metagenomic strategy provides
the species- and gene-level information of the gut microbiota
(Wei et al., 2020b; Liang et al., 2021). Typically, the 16S rRNA
gene amplicon strategy is economical than the metagenomic
strategy and the associated library construction is complex
(Laudadio et al., 2018; Rausch et al., 2019; Shi et al., 2020). The
shallow metagenomic sequencing (SMS) strategy has been
preferred to the 16S rRNA gene amplicon strategy in certain
microbiome studies (Zhu et al., 2021). The use of the SMS
strategy may decrease the costs associated with metagenomic
sequencing strategy (Hillmann et al., 2018; Santiago-Rodriguez
et al., 2020). A comparative analysis of infant gut microbiota
indicated that 16S rRNA gene amplicon and metagenomic
sequencing approaches can provide similar alpha and beta
diversity of the gut microbiota (Peterson et al., 2021).
In this study, we used 16S rRNA gene amplicon and SMS
strategies to provide insights into the gut microbiota of patients
with three colorectal diseases, namely colorectal cancer,
adenoma, and hemorrhoid. We compared alpha and beta
diversities between the two strategies and identified potential
keystone taxa associated with colorectal diseases. Moreover,
antibiotic resistant and other functional gene profiles were
recovered using SMS data. We also discuss the future
prospects of the use of sequencing strategies in determination
of the gut microbiota in colorectal diseases.
MATERIALS AND METHODS
Ethics Statement and Sample Collection
This study was approved by the Institutional Review Board of the
First Affiliated Hospital, Zhengzhou University, Zhengzhou,
Henan Province, China. All patients agreed to participate and
provided written informed consents. Patient details were
anonymized for all analyses.
A total of 16 fecal samples were collected from 16 hospitalized
patients. The 16 patients were allocated to the Group A
(adenoma), Group C (colorectal cancer), or Group H
(hemorrhoids; Supplementary Table S1).
The fecal samples were collected in sterile 5-ml tubes
containing 2 ml DNA/RNA shield liquids, which were
provided by DeepBiome Co., Ltd. The collected samples
were sent to DeepBiome Co., Ltd. for 16S rRNA gene
amplicon and SMS analyses. Patient information including
smoking and alcohol intake history and antibiotic use
history was obtained.
16S rRNA Gene Amplicon Sequencing
The DNA from samples was extracted using DNeasy PowerSoil
Kit (Qiagen, Germany). Approximately 500 µL of the fecal sample
from each tube was used for DNA extraction. The DNA was
quantified using Nanodrop 2000 (Thermo Fisher Scientific,
United States), and the V3-V4 regions of the 16S rRNA gene
sequences were amplified using KAPA HiFi HotStart ReadyMix
PCR Kit KK2600 (Roche Sequencing, South Africa), according to
the manufacturer’s instructions. The amplified PCR fragments
were purified and mixed (Liang et al., 2019; Jiang et al., 2020; Mai
et al., 2020). The sequencing of mixed PCR fragments was
performed by DeepBiome Co., Ltd.
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16S rRNA Amplicon Data Analyses
The raw fastq files were processed using atlas-utils, and barcode
and low-quality sequences were filtered using Trimmomatic (Wei
et al., 2020a). After filtering, the chimeric reads were removed using
atlas-utilis. Paired-end reads were merged with default parameters
by using Usearch software v.11.0.667. Finally, the sequences were
classified into operational taxonomic units (OTUs), with a cutoff of
97% identity (Cole et al., 2014). The OTU tables were generated
using Usearch software. The alpha parameters of the samples were
generated using the Usearch alpha_div tool (Wei et al., 2020a). The
beta-diversity distance and differences between the samples and the
OTU table were evaluated using the Usearch beta_div tool. The
unweighted pair–group method with arithmetic mean (UPGMA)
was used, and principal coordinates analysis (PCoA) was
performed using R software. MetagenoNets was used to infer
microbial networks in the study groups (Nagpal et al., 2020). A
Pearson vanilla algorithm was used for network construction. The
p value was significant at 0.05, and the critical r-value cutoff was 0.7
(Li et al., 2021). The network figures were generated according to
the instructions of MetagenoNets (Nagpal et al., 2020).
Metagenomic Sequencing
The DNA used for the SMS was the same as that used for 16S
rRNA amplicon sequencing. The DNA was quantified using Qubit
dsDNAHS assay kit (12640ES60, Yeason Biotechnology, Shanghai,
China). KAPA HyperPrep Kit (Illumina; KK8504), KAPA Dual-
Indexed Adapters (KK8722), KAPA pure beads, and KAPA
Library Quantification Kit (KK4824) were used to construct the
SMS library (Liang et al., 2021). The SMS library was sequenced
using the Illumina platform, and approximately 1 Gbp data were
generated after sequencing.
SMS Data Analyses
The quality of raw SMS data was evaluated using FastqQC (version
0.11.9), and adaptor sequences in raw reads were removed using
Trimmomatic (version 0.38 (Bolger et al., 2014). Kraken2 was used
for taxonomic classification of SMS data. The sequence reads were
assembled using metaSPAdes (version 3.13.2) with the parameters
of −k 21,33,55 (Nurk et al., 2017). eggnog-mapper (version 0.12.7)
was used for COG term assignment, with KOfam parameters of −e
1e-3 (Huerta-Cepas et al., 2017). The gene-level TPM values of the
genes were calculated (Wei et al., 2019). AMRFinder Plus (version
3.1.1b) was used to annotate the antimicrobial resistance genes in
the SMS data (Feldgarden et al., 2019).
All 16S rRNA gene amplicon and SMS data were deposited in
the GenBank database, with the BioProject accession number of
PRJNA725613, with the BioSample accession numbers of
SAMN1889570-SAMN18895718, the SRA accession numbers
of 16S rRNA data are SRR14410510-SRR14410525, the SRA
accession numbers of SMS data are SRR14460530-SRR14460545.
RESULTS
Microbial Profiles of the Samples
The numbers of samples obtained from Groups A, C, and H were
6, 4, and 6, respectively (Supplementary Table S1). The 16S
rRNA gene fragment sequencing generated 1,457,234 reads, with
an average of 91,077 sequences per sample (Supplementary
Table S1). The sizes of SMS data for these samples were
0.45–5.76 G (average: 1.6 G) (Supplementary Table S2).
The sequences of these samples were classified into OTUs
based on 97% identity. The OTUs ranged from 105 to 314
(Table 1). The average OTUs of Groups A, C, and H were
162.17 ± 32.79, 251.75 ± 21.36, and 239.83 ± 52.05,
respectively (Table 1). Group C demonstrated to have the
highest diversity (Table 1), although no significant difference
in diversity was observed among the groups. SMS data also
demonstrated similar results, with Group C having the highest
diversity (Supplementary Table S3).
Microbial Diversity at the Phylum and Genus
Levels
At the phylum level, the most dominant phyla were Bacteroidetes,
Firmicutes, and Proteobacteria (Table 2). The most dominant
phylum in all the groups was Bacteroidetes, with the following
compositions: 44.41 ± 19.76% in Group A, 52.95 ± 7.33% in
Group C, and 59.04 ± 17.41% in Group H (Table 2). The second
most dominant phylum in all the groups was Firmicutes, and its
percentage in Group C was higher (40.44 ± 6.63%) than in
Groups A and H. Proteobacteria was the third most dominant
phylum, with a higher percentage in Group A (24.97 ± 20.75%)
than in Group C (3.95 ± 1.74%) and Group H (8.28 ± 12.12%;
Table 2). The percentage of Fusobacteria in Group A (3.16 ±
6.20%) was higher than in Group C (0.4 ± 0.77%) and Group
H (0.07 ± 0.08%; Table 2). The 16S rRNA gene data revealed that
the microbial distribution was different in samples from the same
groups at phylum and genus levels (Supplementary Figure S1).
The SMS data were similar to the 16S rRNA data, although the
richness of SMS data was higher than that of 16S rRNA data
(Table 1 and Supplementary Table S2). Bacteroidetes,
Firmicutes, and Proteobacteria (Supplementary Table S4)
were the most dominant phyla in the samples. However, their
compositions in the groups were found to differ between 16S
rRNA and SMS data (Table 2 and Supplementary Table S4).
Importantly, the percentage of Bacteroidota in Group A was
49.76%, whereas it was 61.66 and 75.79% in Groups C and H,
respectively (Supplementary Table S4). The percentage of
Bacteroidota in Groups C and H based on SMS data was
higher than its corresponding composition in each group
based on 16S rRNA data (Table 2 and Supplementary Table S4).
Based on 16S rRNA data, the most dominant genera were
assigned to Bacteroides, Prevotella, Escherichia or Shigella,
Faecalibacterium, and Blautia (Table 3). Bacteroides and
Prevotella were the most dominant genera in all the groups
(Table 3). The percentages of Bacteroides in Groups A, C, and H
were 28.88 ± 23.70%, 22.2 ± 19.66%, and 33.8 ± 25.05%, respectively
(Table 3). The percentages of Prevotella in Groups A, C, and H were
14.41 ± 27.19%, 26.28 ± 24.78%, and 23.12 ± 28.32%, respectively
(Table 3). Although the genus compositions of the groups were
different, no significant difference was observed between each group.
The SMS data were similar to 16S rRNA data in terms of genus
compositions. According to SMS data, the most dominant genera in
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all the groups were Bacteroides and Prevotella, and their
compositions in each group were similar (Table 3 and
Supplementary Table S5). Overall, microbial compositions at the
gene level were consistent between 16S rRNA and SMS data (Table 3
and Supplementary Table S5).
Dominant Species in the Samples
Nearly all the representative sequences of dominant OTUs
demonstrated >97% identity with known isolates, indicating
that most microbes in the samples could be cultured (Table 4)
(Lagier et al., 2016; Bilen et al., 2018). The most dominant OTU,
ZOTU_4, in the groups was assigned as Prevotella copri, which is
a common gut microbe. P. copri is associated with host health,
and its diversity can be affected by the diet (De Filippis et al.,
2019). The microbe has strong carbohydrate metabolism ability;
however, its composition in the western populations is
underrepresented (Tett et al., 2019). In our study, all the
samples were from patients of central China. The high-level
compositions of P. copri were in accordance with the
vegetarian habit in this region. Other dominant OTUs were
assigned to the Bacteroides or Escherichia strains (Table 4).
Two OTUs, namely ZOTU_8 and ZOTU_5, were assigned to
the pathogenic microbes, and their percentages in Group A were
high. The ZOTU_8 composition in sample A5 of Group A was
43.72% and the ZOTU_5 composition in sample A3 of Group A
was 29.76%. These patients (A3 and A5) had symptoms of
inflammation, and it was presumed that strains representing
ZOTU_8 and ZOTU_5 caused these symptoms (Table 4). In
addition, ZOTU_6, ZOTU_10, and ZOTU_17 percentages in
TABLE 1 | Alpha parameters of the three groups based on 16S rRNA gene amplicon data.
Richness Chao1 Shannon_2 Simpson Dominance Equitability
Group A 162.17 ± 32.79 222.95 ± 29.12 3.45 ± 0.78 0.21 ± 0.08 0.79 ± 0.08 0.47 ± 0.09
Group C 251.75 ± 21.36 291.58 ± 11.38 5.15 ± 0.50 0.09 ± 0.06 0.91 ± 0.06 0.65 ± 0.06
Group H 239.83 ± 52.05 295.7 ± 68.72 4.16 ± 0.47 0.16 ± 0.05 0.842 ± 0.05 0.53 ± 0.06
TABLE 2 | Phylum distribution of the three groups based on 16S rRNA gene
amplicon data.
Group A Group C Group H
Bacteroidetes 44.41 ± 19.76% 52.95 ± 7.33% 59.04 ± 17.41%
Firmicutes 26.45 ± 15.22% 40.44 ± 6.63% 30.7 ± 11.69%
Proteobacteria 24.97 ± 20.75% 3.95 ± 1.74% 8.28 ± 12.12%
Fusobacteria 3.16 ± 6.20% 0.4 ± 0.77% 0.07 ± 0.08%
Actinobacteria 0.97 ± 1.21% 0.66 ± 0.17% 1.85 ± 1.83%
Others 0.01 ± 0.06% 0.32 ± 2.25% 0.01 ± 0.09%
TABLE 3 | Genera distribution of the three groups based on 16S rRNA gene amplicon data.
Group A Group C Group H
Bacteroides 28.88 ± 23.70% 22.2 ± 19.66% 33.8 ± 25.05%
Prevotella 14.41 ± 27.19% 26.28 ± 24.78% 23.12 ± 28.32%
Above_genus 13.01 ± 20.23% 17.79 ± 10.74% 11.17 ± 4.93%
Escherichia/Shigella 13.86 ± 10.47% 0.84 ± 1.21% 5.85% ± 12.01
Faecalibacterium 0.91 ± 1.06% 5.29 ± 3.57% 4.36 ± 3.32%
Streptococcus 5.82 ± 11.88% 0.1 ± 0.11% 0.22 ± 0.38%
Blautia 1.67 ± 1.61% 1.85 ± 0.86% 2.62 ± 2.85%
Megamonas 0.03 ± 0.02% 4.72 ± 6.10% 2.08 ± 1.6%
Lachnospiracea_incertae_sedis 0.87 ± 1.10% 1.45 ± 1.31% 2.3 ± 3.01%
Veillonella 3.56 ± 5.90% 0.05 ± 0.05% 0.28 ± 0.46%
Fusobacterium 3.15 ± 6.19% 0.4 ± 0.77% 0.07 ± 0.08%
Phascolarctobacterium 0.93 ± 1.81% 1.4 ± 1.92% 0.99 ± 1.87%
Roseburia 1.06 ± 1.71% 1.2 ± 0.85% 0.86 ± 0.65%
Bifidobacterium 0.71 ± 0.9% 0.24 ± 0.15% 1.73 ± 1.8%
Parabacteroides 0.9 ± 1.30% 1.39 ± 0.97% 0.73 ± 0.64%
Ruminococcus 0.47 ± 1.07% 1.22 ± 1.29% 1.12 ± 1.60%
Clostridium_XlVa 0.76 ± 0.90% 1.84 ± 1.59% 0.42 ± 0.36%
Clostridium_sensu_stricto 2.22 ± 2.90% 0.12 ± 0.18% 0.07 ± 0.07%
Oscillibacter 0.1 ± 0.17% 1.1 ± 1.53% 1.27 ± 2.39%
Sutterella 0.56 ± 1.31% 0.29 ± 0.59% 0.97 ± 1.98%
Alistipes 0.01 ± 0.01% 1.62 ± 0.97% 0.54 ± 0.54%
Ruminococcus2 0.35 ± 0.47% 0.48 ± 0.63% 0.91 ± 1.23%
Haemophilus 1.08 ± 1.26% 0.27 ± 0.47% 0.09 ± 0.08%
Dialister 0.19 ± 0.44% 1.12 ± 1.83% 0.4 ± 0.57%
Parasutterella 0.05 ± 0.09% 0.2 ± 0.30% 0.83 ± 0.90%
Romboutsia 0.83 ± 1.43% 0.12 ± 0.06% 0.1 ± 0.08%
Dorea 0.14 ± 0.13% 0.55 ± 0.60% 0.38 ± 0.24%
Anaerostipes 0.21 ± 0.26% 0.2 ± 0.20% 0.45 ± 0.72%
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sample A6 of Group A were 29.29, 17.44, and 14.95%,
respectively, which were higher than the corresponding OTU
percentages of other samples in Group A (Table 4). These three
dominant OTUs in sample A6 represented potential
opportunistic pathogenic bacteria, which were possibly
responsible for the serious adenoma symptoms (Table 4).
Compared with 16S rRNA gene amplicon data, SMS data
can provide species-level information. Based on SMS data, the
most dominant species were assigned to P. copri, B. dorei, B.
vulgatus, and few other Bacteroides genera (Supplementary
Table S6). The percentages of Streptococcus pasteurianus and
Klebsiella quasipneumoniae in samples A3 and A5 were 18.48
and 29.17%, respectively, which were similar to those obtained
with 16S rRNA data. Some B. fragilis strains could serve as
driver species in colorectal cancer (Haghi et al., 2019; Wong
and Yu, 2019; Butt et al., 2021). The percentages of B. fragilis in
Groups A, C, and H were 3.96, 0.17, and 0.43%, respectively.
The percentages of another potential colorectal cancer driver
species of E. coli in Groups A, C, and H were 2.83, 0.02, and
0.11%, respectively (Supplementary Table S6). The F.
nucleatum percentage was not high (<0.01%) in the groups
(Shang and Liu, 2018; Brennan and Garrett, 2019), suggesting
the presence of other passenger opportunistic species in
patients with colorectal cancer (Wong and Yu, 2019). The
microbial compositions in 16S rRNA and SMS data were
different, although the microbial structures were similar
(Table 4 and Supplementary Table S6). Most microbes
could be assigned at the species level, suggesting the
possibility of isolating the human gut bacteria (Lagier et al.,
2016; Bilen et al., 2018).
Group Analysis of the Samples Based on
16S rRNA Data
The beta-diversity analyses based on both 16S rRNA and SMS
data revealed that samples from Groups A, C, and H overlapped
with each other, with no significant difference (Figure 1). The
UPGMA analysis based on 16S rRNA data demonstrated that
samples from the same groups had different microbial profiles
(Figure 1A). Samples H2, A4, A5, H4, and C4 were clustered, and
so were samples H1, C2, and C3. Samples A1 and A3 and samples
H6 and A6 were clustered (Figure 1A). The SMS data indicated
the same results (Figure 1B). Samples A1 and A3 were clustered,
and so were samples H2, A4, H4, and C4 (Figure 1B). The 16S
rRNA data and the SMS data were similar (Figure 1). The
phylum level distribution of these samples used for the
UPGMA analysis further suggests that the 16S rRNA data
were similar to the SMS data (Figure 1). The PCoA analysis
was consistent with the UPGMA analysis (Figure 1 and
Supplementary Figure S2).
The network analysis can indicate potential microbes
associated with the disease, and keystone taxa can be predicted
based on the microbiota data (Li et al., 2021). The most dominant
54 OTUs with a composition of >0.5% in the samples were
selected for network construction. Three networks were
generated (Figure 2). The edges for Groups A, C, and H were
247, 401, and 241, respectively (Figure 2 and Supplementary
Table S7), and the diameters of the three groups were different.
The densities of Groups A and Group H were similar, whereas
that of Group C was higher than those of other groups. The
average network degrees of Groups A and H were nearly 9, and
that of Group C was 14.6 (Supplementary Table S7). These data
revealed that the association in Group C was more complex than
that in the other groups. These findings suggest the complex
microbiota in patients with colorectal cancer and the highly
connected correlation between the species of the microbiota
(Figure 2).
The nodes in all these networks were assigned to Firmicutes,
Bacteroidetes, Proteobacteria, Actinobacteria, and
Fusobacteria. In Group A, the most dominant OTUs
demonstrated positive correlations with other OTUs. Only
four OTUs, namely ZOTU_13, ZOTU_1, ZOTU_61, and
ZOTU_58, demonstrated a negative correlation with other
OTUs (Figure 2A). These four OTUs may represent
pathogenic species and be associated with adenoma in these
patients. The OTUs ZOTU_3, ZOTU_15, ZOTU_24, and
TABLE 4 | OTU distribution of the three groups based on 16S rRNA gene amplicon data.
Group A Group C Group H Isolated microbes (accession numbers) Identity (%)
ZOTU_4 4.46 ± 10.67% 17.97 ± 16.47% 17.68 ± 20.21% Prevotella copri strain Pc (MT152634.1) 100.00
ZOTU_1 13.86 ± 10.47% 0.84 ± 1.21% 5.85 ± 12.01% Escherichia coli strain LWY6 (CP072204.1) 100.00
ZOTU_3 6.52 ± 11.03% 3.44 ± 5.56% 6.06 ± 9.91% Bacteroides vulgatus strain ADE11 (MT268992.1) 100.00
ZOTU_2 8.42 ± 20.27% 2.6 ± 3% 4.23 ± 6.37% Bacteroides coprocola (NR_041278.1) 100.00
ZOTU_6 5.7 ± 11.66% 2.37 ± 4.27% 6.45 ± 12.83% Bacteroides dorei strain 8,642 (MT464394.1) 100.00
ZOTU_7 0.15 ± 0.28% 6.98 ± 9.16% 8.04 ± 13.95% Bacteroides plebeius DSM 17135 (NR_041277.1) 100.00
ZOTU_9 6.92 ± 16.84% 1.36 ± 2.54% 3.08 ± 7.3% Prevotella copri strain DSM 108494 (MN537545.1) 100.00
ZOTU_8 7.41 ± 17.79% 0.04 ± 0.04% 0.1 ± 0.1% Klebsiella pneumoniae subsp. Pneumoniae strain S1 (MW815592.1) 100.00
ZOTU_5 5.11 ± 12.08% 0 ± 0.01% 0.16 ± 0.37% Streptococcus pasteurianus strain 2,323 (MT604782.1) 100.00
ZOTU_13 0.03 ± 0.02% 4.72 ± 6.1% 2.08 ± 1.6% Megamonas funiformis strain JCM 14723 (CP048627.1) 100.00
ZOTU_39 0.09 ± 0.2% 3.82 ± 6.45% 1.93 ± 4.58% Prevotella copri DSM 18205 (NR_113411.1) 100.00
ZOTU_10 3.07 ± 7.04% 0.58 ± 1.12% 0.37 ± 0.63% Bacteroides fragilis strain ADE7 (MT268985.1) 100.00
ZOTU_21 0.1 ± 0.11% 1.09 ± 0.77% 2.9 ± 3.69% Merdimonas faecis strain BR31 (NR_157642.1) 95.70
ZOTU_30 0.46 ± 0.84% 1.96 ± 2.7% 1.76 ± 2.44% Faecalibacterium prausnitzii A2-165 strain JCM 31915 (CP048437.1) 100.00
ZOTU_18 0.93 ± 0.93% 0.64 ± 0.42% 2.01 ± 2.89% Lachnospiraceae bacterium strain AGP2-03-00-02 (MH699332.1) 100.00
ZOTU_24 0.51 ± 1.04% 1.13 ± 1.62% 1.54 ± 2.21% Lactobacillus rogosae strain ATCC 27753 (NR_104836.1) 100.00
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ZOTU_25 had more positive correlations than other OTUs,
suggesting their importance in these samples. In Group C, both
positive and negative correlations were present, and the
correlations between different species were complex
(Figure 2B). The keystone taxa in Group C could be
ZOTU_4, ZOTU_20, ZOTU_7, ZOTU_13, and other OTUs.
These OTUs are not potential pathogens, but some of themmay
serve as passenger microbes. Similar to Group A, the main
correlations in Group H were positive (Figure 2C). Only
ZOTU_13, ZOTU_44, and ZOTU_21 had negative
correlations with other species (Figure 2C). Compared with
the network of Group C, that of Group H was simple. The
predicted keystone taxa of Group H were not pathogens, and
most of them were normal human gut microbes (Figure 2C).
Functional Profiles of the Microbiota
The assembly of SMS data generated large amounts of contigs.
The assembly quality was related to the generated data. The
contig N50 of all the samples ranged from 2,352 to 9,593 bp
(Supplementary Table S8). The largest contigs were as high as
64.33 kbp (Supplementary Table S8). The open reading frame
(ORF) in the contigs was annotated using the KEGG database. At
FIGURE 1 | UPGMA phylogenetic tree based on (A) 16S rRNA data and (B) SMS data.
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the catalog level, the TPM values of Groups A and H were higher
than that of Group C (Figure 3A). Specifically, the carbohydrate
metabolism and other energy and nutrient uptake metabolism are
important for microbial growth, suggesting the possible
dysfunctional microbiota of Group C (Figure 3A). At the
module and pathway levels, the distribution of Group C was
lower than that of other two groups (Figures 3B,C). The low
distribution of these metabolic catalogs in Group C suggests that
the metabolic ability of gut microbiota in Group C was weak, and
the microbiota of patients in Group C could be imbalanced
(Figure 3B) (Gagnière et al., 2016). Some antimicrobial
resistance genes were identified in some samples, and these
included the antibiotic resistance genes for tetracycline,
macrolide, beta-lactam, and aminoglycoside (Figure 4)
(Feldgarden et al., 2019). The TPM value of tetracycline
resistance gene in Group H was higher than the corresponding
values in Groups A and C. For other antibiotic resistance genes,
most TPM values of Group A were higher than the corresponding
values of Groups C and H (Figure 4). The antibiotics tetracycline,
macrolide, and beta-lactam are commonly used in clinical settings;
however, their overuse could result in the high availability of
corresponding antibiotic resistance genes in such samples.
DISCUSSION
Colorectal cancer is the third most common cancer and the
second leading cause of cancer-related mortality, which suggests
the importance of investigating the molecular mechanisms of
colorectal carcinogenesis (Sung et al., 2021). Environmental
factors, particularly gut microbes, play pivotal roles in causing
colorectal diseases (Czene et al., 2002; Song and Chan, 2019).
Core microbiota has been found in the gut microbiota of patients
with colorectal cancer, and a study recovered the microbiota of
patients with adenoma (Click et al., 2018; Saito et al., 2019).
Colorectal cancer typically develops from adenoma, whereas
hemorrhoids are a common colorectal disease. Comparison of
these colorectal diseases may provide insights into the causative
factors for colorectal carcinogenesis (Wong and Yu, 2019). In this
study, we used 16S rRNA gene amplicon and SMS strategies to
investigate the gut microbiota of patients with colorectal cancer,
adenoma, and hemorrhoids.
Microbial profiling revealed higher diversity in Group C than
in other groups, which is consistent with previous results that
indicated higher microbiota diversity in patients with colorectal
cancer than in healthy individuals (Tilg et al., 2018; Reis et al.,
2019). The difference in microbiota diversity could be attributed
to the increase in microbial diversity due to dysbiosis of gut
microbiota of patients with colorectal cancer (Gao et al., 2015).
The richness based on SMS data was higher than that based on
16S rRNA gene amplicon data. Metagenomic data can provide
species-level microbial information, but it can lead to the
overestimation of microbial richness (Wang et al., 2015). Some
driver and passenger microbes were identified in the samples, but
the percentages of certain known passenger species, such as F.
nucleatum, were low (Tjalsma et al., 2012; Wong and Yu, 2019).
Different ethnic groups of patients living in different areas may
FIGURE 2 | Network analysis of the gut microbiota of the three groups
based on correlation analysis. (A) the network analysis of group A; (B) The
network analysis of Group C; (C). The network analysis of Group H.The size
of each node is proportional to the node degree. The lines between two
nodes colored in blue indicate positive correlation, whereas the lines between
two nodes colored in blue indicate negative correlation.
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FIGURE 3 | TPM values of the annotated ORFs at the (A) catalog level, (B) module level, and (C) pathway level.
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have diverse gut microbiota (Dai et al., 2018; Deschasaux et al.,
2018; Verhaar et al., 2020). Therefore, it is possible that unknown
passenger species may be present in patients of central China with
colorectal disease. Although certain potential species were
identified according to the network analysis, further studies
based on pure cultures isolated from the gut microbiota are
required to investigate their functional roles (Lagier et al., 2016;
Bilen et al., 2018). In future, verification of the keystone taxa in
colorectal carcinogenesis could help in identifying biomarkers for
the diagnosis and prevention of colorectal diseases, including
colorectal cancer (Lagier et al., 2016; Bilen et al., 2018).
Moreover, modulation of the colorectal disease microbiota with
probiotics or other strategies will confer health benefits to humans,
which will be a value addition to the treatment paradigm (Durack
and Lynch, 2019; Peng et al., 2020).
The gut microbiota is affected by diet and other environmental
factors (Grazioso et al., 2019; Illiano et al., 2020). The functional
profiles of the gut microbiota in the groups were different, and the
metabolic catalogs of Group C were lower than those of Groups A
and H. This finding indicates that the high microbial diversity of
Group C could have caused dysbiosis of the microbial metabolism
(Gagnière et al., 2016; Song and Chan, 2019). The identification of
certain pathogenic microbes, such as K. pneumoniae and S.
pasteurianus, in the samples revealed the potential of microbial
analyses to recognize infective microbes in patients (Gu et al., 2021).
Diverse antibiotic resistance genes were identified in SMS data. This
could be due to the fact that antibiotics were administered to the
hospitalized patients (Bullman et al., 2017; Cao et al., 2018).
Prevotella and other gut microbes can be identified in oral
microbiota (Yamashita and Takeshita, 2017; Qiao et al., 2020),
and the oral microbiota of patients with colorectal diseases are
different from that of healthy individuals (Russo et al., 2017; Flemer
et al., 2018). Therefore, it is possible to classify or predict potential
patients with colorectal diseases based on oral microbiota
(Yamashita and Takeshita, 2017; Flemer et al., 2018). Moreover,
diets can reshape the gut microbiota, implying that designing and
implementing an optimized diet by using active components of
plants can be an effective therapeutic strategy for colorectal diseases
in the near future (Guan et al., 2020; Wang et al., 2020).
The metagenomic strategy had been widely used to identify
keystone taxa in human microbiome (Saito et al., 2019). The
metagenomic strategy is rapid and accurate, and could provide
species- and gene-level information of the microbiota (Wang
et al., 2015). However, the associated cost is high, and analysis of
these data requires investment of massive computer resources
(Zhu et al., 2021). The SMS approach is an affordable and rapid
microbial detection strategy. Although phylum- and genus-level
data are slightly different, SMS and 16S rRNA amplicon data
provided similar microbial structures in this study. In addition,
SMS data shed light into the species- and gene-level information,
which can drive future identification of reliable microbial or gene
biomarkers for diagnosis and treatment of colorectal diseases
(Hillmann et al., 2018; Zhu et al., 2021).
In this study, we recovered gut microbiota from patients with
three different colorectal diseases and identified the potential
keystone taxa. In addition to pathogenic microbes in a few
adenoma disease samples, certain passenger microbes could
have roles in causing colorectal diseases. The 16S rRNA gene
amplicon and SMS data provide similar alpha- and beta-diversity
results, and SMS data may be applied for future clinical use in
colorectal diseases. In future, designing an appropriate diet to
modulate the gut microbiota may be beneficial for the prevention
or treatment of colorectal diseases.
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